• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Issues that matter
    • COVID-19 in India
    • Inadequate safe drinking water
    • Poor sanitation
    • Environmental health
    • Infectious disease
      • Hepatitis C
    • Noncommunicable Diseases (NCDs)
    • Malnutrition
    • High infant mortality
    • Mental health
    • Sex and gender discrimination
  • Special Focus
    • Interviews
      • Exclusive Interviews
      • Readers Interviews
    • Vaccine Hesitancy
  • News
  • PandemiCast
  • Partner’s Press Office

Health Issues India

Health issues in India

  • Home
  • About Us
  • Editorial Team
  • Subscribe
  • Contribute
  • Sponsor
  • Contact Us
You are here: Home / Access to Healthcare / India to become the pharmacy of the Philippines?

India to become the pharmacy of the Philippines?

December 11, 2017 By Kerean Watts Leave a Comment

President Rodrigo Roa Duterte and Indian Prime Minister Narendra Modi pose for a photo prior to the start of the bilateral meeting at the Philippine International Convention Center in Pasay City on November 13, 2017. ROBINSON NIÑAL JR./PRESIDENTIAL PHOTO
President of the Philippines Rodrigo Duterte (left) and Indian Prime Minister Narendra Modi (right) at the Philippine International Convention Centre in Pasay City. 

President of the Philippines Rodrigo Duterte is keen to capitalise on India’s generic medicines industry.

Biateral talks occurred last month between Duterte and Prime Minister Narendra Modi at the Philippine International Convention Centre in Pasay City. During the talks, Duterte noted the potential of India’s pharmaceutical industry to expand into the Philippines. The proposal came as part of a broader discussion which saw agreements signed on agriculture, defence, foreign services and trade.

‘Medicines people can really afford to buy’

‘You have [medicines]…people can really afford to buy’, Duterte is reported to have said to Modi. He invited potential investors from India to visit the Philippines and open branches in the country. He said ‘we would [be]happy to see you building an investment that would include the medicines.’

‘You go to any other place…it’s very expensive’, Duterte added. He singled out the United States, saying American drugmakers ‘don’t believe in generics because they do not make any money.’ Duterte championed the ‘cheaper, almost socialised pricing’ of Indian medicines.

India’s high-volume output of cheap generic medicines has earned it the title of ‘pharmacy of the developing world’. This has become a cornerstone of trading relations.

India has signed agreements in the past to supply generic medicines to Fiji, South Africa and Venezuela, among others. The ability to avail low-cost treatments also makes India a hotspot of medical tourism, numbers of which are predicted to double by 2021. Since Modi’s talks with Duterte, similar collaborations have been announced with Italy and Cuba.

Modi welcomed the discussion, calling it ‘productive’ in a Tweet. He closed the meeting by inviting Duterte to visit India in January 2018 – an invitation the President is said to have tentatively accepted,saying ‘God willing, I will be there.’

Filed Under: Access to Healthcare, Featured, Government policy, International, Medicine and Research, News, Science and Technology Tagged With: access to medicines, Features, Generics, Narendra Modi, pharma

About Kerean Watts

Kerean Watts has been a featured writer for Health Issues since 2016. His areas of study include politics, international relations and global development. He is based in South Wales.

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Articles

  • Renewed fears of a bird flu pandemic; The latest health stories from around the world
  • More oversight needed for “gain of function” research says expert panel; The latest health stories from around the world
  • Marion Biotech to be investigated by Indian drug regulator
  • Sesame to be added to list of major food allergens
  • Approval of Alzheimer’s drug “rife with irregularities”

Footer

Archives

Issues that matter

  • Environmental health
  • Inadequate safe drinking water
  • Poor sanitation
  • Infectious disease
  • Noncommunicable Diseases (NCDs)
  • Malnutrition
  • High infant mortality

Categories

Copyright © 2023 · News Pro On Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
Cookie settingsACCEPTACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.